<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02872974</url>
  </required_header>
  <id_info>
    <org_study_id>2016-00745-C</org_study_id>
    <nct_id>NCT02872974</nct_id>
  </id_info>
  <brief_title>Gestational Diabetes and Offspring's Cardiovascular Health: MySweetHeart Cohort</brief_title>
  <official_title>Consequences of Maternal Gestational Diabetes on Offspring's Cardiovascular Health: MySweetHeart Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      MySweetHeart Cohort is an observational study to assess the effect of gestational diabetes
      mellitus (GDM) on early life offspring's cardiovascular health.

      The primary objective is to assess the effect of GDM on the surrogate markers of
      cardiovascular disease (CVD) at birth (left ventricular mass index and subclinical
      atherosclerosis). The secondary objective is to assess the effect of GDM on the
      cardiovascular structure and function during the fetal period and neonatal adverse
      cardiovascular risk factors.

      The main hypothesis is that offspring of women with GDM have a larger LVMI and a larger cIMT
      at birth (primary outcomes) compared with offspring of women without GDM. Further, other
      hypotheses are that offspring of women with GDM have more foetal cardiovascular alterations
      and adverse neonatal cardio-metabolic risk factors (secondary outcomes) compared with
      offspring of women without GDM.

      My SweetHeart Cohort is linked to MySweetHeart Trial, a randomized controlled trial assessing
      the effect of a multidimensional interdisciplinary lifestyle and psychosocial intervention to
      improve the cardio-metabolic and mental health of women with GDM and their offspring. The
      principal investigators of this trial are Prof Jardena Puder and Dr Antje Horsch from
      Lausanne University Hospital.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Not available
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular mass index</measure>
    <time_frame>At birth</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Carotid intima-media thickness</measure>
    <time_frame>At birth</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fetal cardiovascular alterations</measure>
    <time_frame>30-34 wks of gestation (During fetal life)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fetal left ventricular mass index</measure>
    <time_frame>30-34 wks of gestation (During fetal life)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fetal liver volume</measure>
    <time_frame>30-34 wks of gestation (During fetal life)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular risk factors</measure>
    <time_frame>At birth</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <condition>Gestational Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Exposed</arm_group_label>
    <description>Offspring of woman with GDM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Not exposed</arm_group_label>
    <description>Offspring of woman without GDM</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>GDM</intervention_name>
    <description>Exposure to GDM during fetal life</description>
    <arm_group_label>Exposed</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Not available
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        We will include the offspring of 100 women with GDM and of 100 women without GDM. They will
        be recruited at 24-32 wks of gestation and will be followed-up with their offspring until
        birth. Primary outcomes will be measured shortly (2-7 days) after birth. Secondary outcomes
        will be measured during the foetal period (30-34 wks of gestation), at birth, and shortly
        (2-4 days) after birth. A long-term follow-up of these children is planned.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Women aged 18 yrs or older, with or without GDM at 24-32 weeks of gestation, and
        understanding French or English.

        Exclusion Criteria:

        Women on strict bed-rest, with pre-existing diabetes or known severe mental disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicole Sekarski, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Lausanne Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicole Sekarski, Prof</last_name>
    <email>nicole.sekarski@chuv.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arnaud Chiolero, MD PhD</last_name>
    <email>arnaud.chiolero@chuv.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lausanne University Hospital</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1005</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Sekarski, Prof</last_name>
      <email>nicole.sekarski@chuv.ch</email>
    </contact>
    <contact_backup>
      <last_name>Sandrine Estoppey</last_name>
      <email>Sandrine.Estoppey@chuv.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Nicole Sekarski, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yvan Mivelaz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefano Di Bernardo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yvan Vial, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascal Bovet, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Umberto Simeoni, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arnaud Chiolero, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2016</study_first_submitted>
  <study_first_submitted_qc>August 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2016</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne Hospitals</investigator_affiliation>
    <investigator_full_name>Nicole Sekarski</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Cardiovascular diseases</keyword>
  <keyword>Gestational diabetes mellitus</keyword>
  <keyword>Pediatrics</keyword>
  <keyword>Fetal programming</keyword>
  <keyword>Cohort study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Plan to share data has to be defined</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

